Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-E...(525 Cash and Cash Equivalents at End ...)

Cash and Cash Equivalents at End of Period $866 $1,460

Monsanto Company

Selected Financial Information

(Dollars in millions)

Unaudited

(1) All earnings per share figures have been adjusted to reflect the

company's two-for-one stock split which was paid on July 28, 2006, in

the form of a 100 percent stock dividend.

(2) EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT,

ongoing EPS and free cash flow are not intended to replace net income

(loss), cash flows, financial position or comprehensive income

(loss), and they are not measures of financial performance as

determined in accordance with generally accepted accounting

principles (GAAP) in the United States. The following tables

reconcile EBIT, ongoing EPS and free cash flow to the respective most

directly comparable financial measure calculated in accordance with

GAAP.

Reconciliation of EBIT to Net Income (Loss): EBIT is defined as

earnings (loss) before interest and taxes. Earnings (loss) is

intended to mean net income (loss) as presented in the Statements of

Consolidated Operations under GAAP. The following table reconciles

EBIT to the most directly comparable financial measure, which is net

income (loss).

Three Months 12 Months

Ended Ended

Aug. 31 Aug. 31,

2007 2006 2007 2006

EBIT - Seeds and Genomics Segment $(397) $(228) $905 $794

EBIT - Agricultural Productivity

Segment
'/>"/>